Pfizer: Depo-Provera (medroxyprogesterone acetate) injectable suspension: highlights of prescribing information. 201n5a. Available at: http://labeling. pizer.com/ShowLabeling.aspx?id = 522. Accessed October 11,n2016 Pfizer: Depo-subQ Provera 104: physician information. 2015b. Available at: http://labeling.pizer.com/ShowLabeling.aspx?id = 549. Accessed October 11,n2016 Phillips SJ, Tepper NK, Kapp N, et al: Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception 94(3):226, 2015 Raps M, Curvers], Helmerhorst FM, et al: hyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives. hromb Res 133(4):640,n2014 Remington KM, Buller RS, Kelly JR: Efect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by StaphyLococcus aureus. Obstet Gynecol 69:563, 1987 Rickert VI, Tiezzi L, Lipshutz J, et al: Depo Now: preventing unintended pregnancies among adolescents and young adults.] Adolesc Health 40(1):22,2007 Robinson GE, Burren T, Mackie IJ, et al: Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgely. BMJ 302:269, 1991 Rodriguez MI, Godfrey EM, Warden M, et al: Prevention and management of nausea and vomiting with emergency contraception: a systematic review. Contraception 87(5):583, 2013
Ronnerdag M, Odlind V: Health efects of long-term use of the intrauterine levonorgestrel-releasing system. Acta Obstet Gynecol Scand 78:716, 1999 Rothman KJ, Louik C: Oral contraceptives and birth defects. N Engl J Med 299:522, 1978
Saav I, Stephansson 0, Gemzell-Danielsson K: Early versus delayed insertion of intrauterine contraception ater medical abortion-a randomized controlled trial. PLoS One 7(11):e48948, 2012
Samson M, Porter N, Orekoya 0, et al: Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat 155(1):3,n2016
Sano M, Nemoto K, Miura T, et al: endoscopic treatment of intrauterine device migration into the bladder with stone formation. J Endourol Case Rep 3(1):105,n2017
Savolainen E, Saksela E, Saxen L: Teratogenic hazards of oral contraceptives analyzed in a national malformation register. Am] Obstet GynecoIn140:521, 1981
Schafer ]E, Osborne LM, Davis AR, et al: Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception 73(5):488, 2006
Schiesser M, Lapaire 0, Tercanli S, et al: Lost intrauterine devices during pregnancy: maternal and fetal outcome after ultrasound-guided extraction. An analysis of 82 cases. Ultrasound Obstet Gynecol 23:486, 2004